Position in EXEL
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$11,443,184
+$2,798,577 QoQ
Shares Held
210,314
+4.3% QoQ
Ownership
0.085%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#126
of 751 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORDEA INVESTMENT MANAGEMENT AB holds $503,679,873 across 20 Biotechnology names. EXEL ranks #6 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
363,479 | $226,643,694 | |
| 2 | RPRX |
Royalty Pharma plc
|
2,576,772 | $144,479,604 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
284,175 | $23,163,103 | |
| 4 | LGND |
Ligand Pharmaceuticals Inc
|
49,943 | $15,786,482 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
30,496 | $15,148,278 | |
| 6 | EXEL |
Exelixis, Inc.
This page
|
210,314 | $11,443,184 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
26,913 | $8,101,620 | |
| 8 | PTGX |
Protagonist Therapeutics, Inc
|
64,964 | $7,963,286 |
All Filings in EXEL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,443,184 | 210,314 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $8,644,607 | 201,553 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $9,340,216 | 213,101 | Shares | Defined | 2026-01-08 | |
| 2025-09-30 | $10,054,856 | 243,459 | Shares | Defined | 2025-10-27 | |
| 2025-06-30 | $10,370,568 | 235,267 | Shares | Defined | 2025-07-29 | |
| 2025-03-31 | $8,643,562 | 234,116 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $7,770,487 | 233,348 | Shares | Sole | 2025-01-06 | |
| 2024-09-30 | $5,761,339 | 222,017 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $3,892,837 | 173,246 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $4,800,389 | 202,292 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $4,138,466 | 172,508 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $3,898,389 | 178,416 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,503,417 | 183,329 | Shares | Sole | 2023-07-07 | |
| 2023-03-31 | $4,994,620 | 257,322 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $4,182,157 | 260,733 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $4,260,397 | 271,709 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $5,718,108 | 274,645 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $6,882,181 | 303,581 | Shares | Sole | 2022-04-11 | |
| 2021-12-31 | $5,491,184 | 300,393 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $6,431,231 | 304,221 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $5,478,116 | 300,665 | Shares | Sole | 2021-07-16 | |
| 2021-03-31 | $6,222,257 | 275,443 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $5,900,038 | 293,973 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $6,712,356 | 274,534 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $12,966,692 | 546,196 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $4,721,327 | 274,177 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||